Novavax Inc (NVAX) is a biotechnology company listed on US.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Use this NVAX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NVAX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NVAX SEC filings page. Lician reads the product cache first so this HTML stays unique to Novavax Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NVAX income, balance, and cash tables.